Albuterol Solution
Product Images NDC 0378-7057

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Albuterol (NDC 0378-7057). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Albuterol Sulfate Inhalation Solution 0.63 mg/3 mL Carton Label (Image 01)

Packaging label for Albuterol Sulfate Inhalation Solution 0.63 mg/3 mL by Mylan Pharmaceuticals Inc. The label includes dosage strength and form, states it is for inhalation use only, and mentions the carton contains 5 pouches of 5 sterile unit-dose vials each. The label also features the Mylan logo and barcode.*

FDA Label Image

Albuterol Sulfate Inhalation Solution 1.25 mg/3 mL Carton Label (Image 02)

Packaging label for Albuterol Sulfate Inhalation Solution 1.25 mg/3 mL by Mylan Pharmaceuticals Inc. The label specifies the solution is for respiratory inhalation, supplied as sterile unit-dose vials with a carton containing 5 pouches of 5 vials each. The label includes the NDC 0378-7058-52 and directs usage for inhalation only.*

FDA Label Image

Albuterol Sulfate Structural Formula (Image 03)

Chemical structure of albuterol, showing the molecular formula with hydroxyl groups, aromatic ring, side chains, and associated sulfate groups, as depicted in the image.*

FDA Label Image

Figure 1 % Change From Pre-dose Fev1 Intent-to-treat Population Day 1 (Image 04)

A line graph depicting percent change over time (hours from pre-dose) for three treatments: albuterol 1.25 mg, albuterol 0.63 mg, and placebo. The y-axis shows percent change, and the x-axis shows hours from pre-dose, comparing the effects of the two albuterol strengths and placebo over a 6-hour period.*

FDA Label Image

Figure 2 % Change From Pre-dose Fev1 Intent-to-treat Population Day 28 (Image 05)

A line graph displaying percent change over six hours from pre-dose time for Albuterol inhalation solutions at strengths 1.25 mg and 0.63 mg, compared to placebo. The x-axis shows hours from pre-dose and the y-axis shows percent change. The graph includes three lines representing Albuterol 1.25 mg, Albuterol 0.63 mg, and placebo treatments.*

FDA Label Image

Instructions For Use Figure 1 (Image 06)

An illustration labeled as Figure 1 showing a dropper dispensing liquid into a small cup or container positioned below a faucet-like device. The image suggests a step in preparing or administering a respiratory inhalation solution, possibly related to Albuterol solution.*

FDA Label Image

Instructions For Use Figure 2 (Image 07)

Black and white line drawing illustrating the connection of a small component or assembly piece being inserted or attached to a larger inhalation device apparatus, likely related to the use or assembly of a respiratory solution inhaler device.*

FDA Label Image

Instructions For Use Figures 3 And 4 (Image 08)

Illustrations showing the use of a respiratory inhalation device for Albuterol solution. One image depicts a user inhaling through the device mouthpiece, and the other shows the device being used with a face mask covering the nose and mouth, demonstrating two inhalation methods.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.